Wednesday, 6 May 2026
  
Login

Australia's most trusted
source of pharma news

Wednesday, 6 May 2026
Ascott 1
Ascott 1
Aussie class action targets Big Pharma

Proceedings have been filed in the Supreme Court against this Big Pharma over alleged health risks associated with one of its drugs following similar lawsuits overseas.

Look who's opening a US office
With growing demand from global pharma for its AI commercialisation platform, this Aussie company is setting up in Boston
TODAY
Board wipeout hits local company
In less than a month an activist investor has won the resignation of a CEO and changed the entire board of this company
TODAY
Medscape
Medscape
Lilly GM confirms drug launch
Newly approved treatment soon to roll out on private script with Aussie boss acknowledging the "significant challenges" in securing subsidy
5 May
What happened to the PBS in Q1?
There was a significant drop in PBS reimbursements during Q1, but the Department couldn't offer a definitive explanation
5 May
Why pharma hires are quitting
Onboarding at Aussie pharma companies is failing to create emotional attachment to work driving new hires to quit
4 May
Who's made a move to new digs?
While marking a milestone in Australia, this pharma is focused on the future with a long-term commitment to collaboration and innovation
4 May
HPG
HPG
Latest Jobs
Finally... CAR T funded after five years
Fourth CAR T-cell therapy funded in Australia - and the first for multiple myeloma - marking almost 1200 days since it was first submitted
5 May
Sandoz wins consensus on biosims
Stakeholders are united on what needs to be done to increase the uptake of biosims starting with helping the patient hip pocket
5 May
PBS increase to strain Budget
Govt foreshadows that increased spending on subsidising pharmaceuticals will be the third greatest pressure on the Budget
5 May
Aussie discovery goes commercial
First-in-class drug developed from local research has been TGA approved, with the sponsor "exploring" PBS reimbursement
4 May
Blast from the past heads to PBAC
A treatment deferred four years ago is back on the agenda, along with a cancer drug that was marked 'ceased' at the start of April
4 May
siRNA specialist enters Aust market
TGA approves first-in-class siRNA therapeutic, a new brand of Eisai's kinase inhibitor, plus a long list of generics of PBS listed drugs
4 May Approvals Action
Who's won an MA Board seat?
After 10 Country Leaders put up their hand to join the Board of industry peak body, these four made the cut
1 May
Aussie pharma on the nose
Industry's approval rating among patients fell nine per cent, one of the worst global results but not everyone's in the bad books
1 May
Drought strikes May PBS listings
PBS listings have dried up with only three additions to the scheme this month. Find out who won a May listing...
1 May New to the PBS
New Top 25 Big Pharma is born
ICYMI: The buyout of Organon by Sun Pharma will create a new top-ranking pharma plus the other most popular stories this week
1 May Your Week in 5 Minutes
Rising cost of PBAC submissions
Department releases its proposed fee structure for the processes of listing on the PBS, and just how much it expects to raise
1 May
First May PBS listing goes to...
Cancer drug reimbursement win underlines the company's "ongoing investment in oncology" GM says, providing patients more choice
1 May
Which CAR T saved Sam Neill?
An experimental therapy has eliminated Neill's cancer, with the actor describing himself as 'patient zero' for the new treatment
30 April
High-flyers on the move in pharma
Top-level appointments announced including one executive who has switched between the same two companies over eight years
30 April
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.